Rad 101 Detects Brain Metastases in New Clinical Trial
Radiopharm Theranostics announced positive results from a study using a novel imaging approach with RAD 101 (18F-Pivalate) to detect...
eGenesis Announces Success: Second Patient Receives Genetically Engineered Porcine Kidney
eGenesis successfully transplanted a genetically modified pig kidney into a second patient with end-stage kidney disease. The procedure, part...
Cyclo Therapeutics’ Positive Phase 3 Open-Label Sub-Study Data in Young Patients
Cyclo Therapeutics presented data from its pivotal Phase 3 TransportNPC™ trial of Trappsol® Cyclo™ for Niemann-Pick Disease Type C1...
Ampligen® & Flumist®: AIM Immunotech’s Innovative Avian Flu Trial
AIM ImmunoTech Inc. is initiating a plan to further develop Ampligen as a vaccine adjuvant for avian influenza. The...
Eylea HD: 3-Year Results Show Durable Vision Gains in Wet AMD
Regeneron announced positive three-year results from an extension study of the Phase 3 PULSAR trial for EYLEA HD (aflibercept...
Carmat Aeson® Artificial Heart Achieves 100 Implants
CARMAT announced it has implanted its Aeson® artificial heart in 100 patients, a significant milestone reached with the 99th...
Zivo and U. Delaware Combat Avian Flu
ZIVO Bioscience is initiating a second collaborative study with the University of Delaware to further investigate the potential of...
Koru Medical’s Next-Gen Subcutaneous Infusion System
KORU Medical Systems has partnered with a global pharmaceutical company to develop and seek regulatory clearance for a next-generation...
AI-Powered Cardiac Diagnostics for Underserved Florida Communities
AISAP, a medical technology company specializing in AI-powered point-of-care ultrasound diagnostics, has partnered with Amavita Heart and Vascular Health...
Axena Health and Mayo Clinic Partner to Advance Urinary Incontinence Care
Axena Health and Mayo Clinic have partnered to integrate Mayo Clinic’s overactive bladder (OAB) educational content into Axena Health’s...